Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Contingent Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹1,019 Cr₹89 Cr₹48 Cr₹83 Cr₹35 Cr

What is the latest Contingent Liabilities ratio of MANKIND PHARMA ?

The latest Contingent Liabilities ratio of MANKIND PHARMA is ₹1,019 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹1,019 Cr
Mar2024₹89 Cr
Mar2023₹48 Cr
Mar2022₹83 Cr
Mar2021₹35 Cr

How is Contingent Liabilities of MANKIND PHARMA Trending?

Years Contingent Liabilities % Change
Mar2025 ₹1,019 Cr
1,045.33
Mar2024 ₹89 Cr
85.77
Mar2023 ₹48 Cr
-41.97
Mar2022 ₹83 Cr
137.32
Mar2021 ₹35 Cr -

Compare Contingent Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹86,450.6 Cr -0.7% -5.7% -20.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹393,323.0 Cr -2.5% -7% -8% Stock Analytics
DIVIS LABORATORIES ₹160,825.0 Cr -2.2% -7.2% 1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,349.0 Cr -4% 2.8% 27.1% Stock Analytics
CIPLA ₹106,048.0 Cr -5.5% -12.4% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,494.0 Cr 5.9% -3.7% -6.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-0.7%

-5.7%

-20.6%

SENSEX

-1.7%

-4.3%

6.2%


You may also like the below Video Courses